Synexa Life Sciences
Emile Lens is a seasoned executive with extensive experience in leadership roles across various industries. Currently serving as CEO and co-owner of Synexa Life Sciences since October 2019, Emile specializes in biomarker and bioanalytical services for clinical trials and translational studies. Additionally, Emile holds the position of CFO/COO at Avania and co-ownership at Nobilo Ventures, which invests in small and mid-sized companies in the Benelux. Emile's previous roles include Chief Financial Officer at Avania, Factory CRO, Maxeda DIY Group, and a founding partner at Albacore Partners. Emile's finance expertise was further developed at ABN AMRO and MeesPierson, working in mergers and acquisitions and corporate finance. Emile earned an MBA in Business Economics from Erasmus University Rotterdam.
This person is not in any offices
Synexa Life Sciences
Synexa Life Sciences is a global provider of biomarker and bioanalytical services, specialising in the development, validation, and delivery of a wide range of complex and custom-designed assays. With a team of 150 across five global laboratory locations; Cape Town, London, Berlin, Turku (Finland) and Rockville (Maryland USA), we provide innovative solutions to support our customers to achieve their clinical milestones. Our main areas of expertise include biomarker identification and development, clinical bioanalysis, soluble biomarker analysis (utilising MSD, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry and ELISpot) and genomic services to support clinical trials and translational studies. We pride ourselves on our deep scientific expertise and our ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis. We partner with our customers to contribute to the furtherment of scientific development and ultimately better management and treatment of human health. Synexa, improving the quality of human health through innovative biomarker and bioanalytical solutions.